Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.227NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.555NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.555NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.555NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.513NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.513NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.513NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.31NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.31NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.31NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HN.4.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HN.4.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HN.4.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XACNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XACNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XACNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.1.1.11NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.1.1.11NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.1.1.11NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XZNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XZNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XZNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-1230.04Singapore
BF.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.4.6.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.4.6.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.4.6.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBJNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBJNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBJNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EJ.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EJ.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EJ.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DQ.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DQ.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DQ.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.31.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.31.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.31.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.1.77NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.1.77NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.77NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XAY.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XAY.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XAY.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BY.1.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used